Women are looking for new solutions, especially botanicals, to address the symptoms of menopause. But at the same time, science is particularly important in this category, so botanical ingredients with strong clinical substantiation are increasingly important.

Famenity’s MS-10® fits the bill. It is a proprietary blend of natural botanical dietary ingredients extracted from thistle and thyme. In a series of published, peer-reviewed in vitro, in vivo and double-blind randomized placebo-controlled human clinical studies, researchers found that MS-10® exerted significant improvement in alleviating menopausal symptoms, regulating estrogen receptor activity, and improving bone health blood serum markers in menopausal women. 

Join us for this overview of MS-10 with regulatory expert Chanel Kaminis, compliance director for the Bent Creek Institute, who is representing Famenity, the makers of MS-10. Ms. Kaminis will provide an outline of the science and safety data on this proprietary new ingredient. 

Moderator:

Karen Raterman
Associate Director, Content Marketing, Natural Products Insider 

Speaker:

Chanel Kaminis
Compliance Director, the Bent Creek Institute

As compliance director for the Bent Creek Institute (BCI), Ms. Kaminis maintains up-to-date awareness of the U.S. regulatory environment pertaining to dietary supplements, foods and cosmetics. At BCI she specializes in consulting services for the preparation and submission of New Dietary Ingredient Notifications to the U.S. FDA. To-date she has filed seven successful NDIN’s on Famenity’s behalf for a wide range of their dietary supplement products. Most recently she secured an NDIN with FDA for MS-10.